Page last updated: 2024-09-02

deoxyglucose and Allergic Encephalomyelitis

deoxyglucose has been researched along with Allergic Encephalomyelitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ahmed, ME; Bin, R; Cerghet, M; Datta, I; Giri, S; Hoda, MN; Kumar, A; Mangalam, AK; Poisson, LM; Rashid, F; Rattan, R; Singh, J; Suhail, H; Waters, J; Zahoor, I	1

Other Studies

1 other study(ies) available for deoxyglucose and Allergic Encephalomyelitis

Article	Year
Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target. Proceedings of the National Academy of Sciences of the United States of America, 2022, 06-21, Volume: 119, Issue:25 Topics: Animals; Anti-Inflammatory Agents; Antimetabolites; Deoxyglucose; Drug Development; Encephalomyelitis, Autoimmune, Experimental; Glycolysis; Humans; Leukocytes, Mononuclear; Metabolomics; Mice; Multiple Sclerosis, Relapsing-Remitting	2022

Article

Year

Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target.

Proceedings of the National Academy of Sciences of the United States of America, 2022, 06-21, Volume: 119, Issue:25

Topics: Animals; Anti-Inflammatory Agents; Antimetabolites; Deoxyglucose; Drug Development; Encephalomyelitis, Autoimmune, Experimental; Glycolysis; Humans; Leukocytes, Mononuclear; Metabolomics; Mice; Multiple Sclerosis, Relapsing-Remitting

2022